Skip to main content
. 2024 Apr 22;15:3402. doi: 10.1038/s41467-024-47463-6

Fig. 1. Study overview and cohort description.

Fig. 1

a Stage 1, symptomatic cohort: ChAdOx1 nCoV-19 vaccinees are shown in red. MenACWY vaccinees are placebo vaccinees (blue). NAAT+ve are participants with COVID-19, NAAT-ve are people who had COVID-19-like symptoms and thus had a CT visit but were subsequently shown not to have COVID-19 (grey); (b) Stage 2: all participants had COVID-19 (i.e. were NAAT+ve). D0: Baseline visit, before vaccination. CT: COVID-19 test visit. CT + 7: 7 days after CT visit.